Day 3, Thursday, March 20th, 2025Thursday, 20 March 2025 - EST/EDT (Eastern Daylight, GMT-4)

This case study explores EMD Serono’s approach to cultivating a strong company culture and its direct impact on team engagement, retention and productivity. The study defines what company culture is and how it shapes daily operations and employee behavior. It highlights the critical role of leadership in fostering and maintaining a positive work environment and demonstrates how a well-established culture drives employee engagement. The case study also examines how a thriving culture contributes to long-term employee retention and increased productivity, providing actionable strategies for organizations aiming to enhance their internal dynamics.

As PBMs continue deploying accumulators, maximizers and alternative funding programs to drive cost savings, the ripple effects on patients, manufacturers, and healthcare ecosystems are undeniable. This session delivers critical updates on these strategies and offers actionable insights to help your organization stay ahead.

• Identify strategies and unique hub solutions so manufacturers can continue to prioritize patient access and affordability
• Understand the current state of employer perspectives and the impact on patients
• Stay informed on evolving state and federal regulatory developments affecting these programs

• Overview copay smoothing to understand what it is, how it differs from traditional Part D benefit structure and its overall mechanics.

• Highlight the advantages of copay smoothing for patients whilst also discussing the challenges and opportunities for health plans and other stakeholder groups.

• Discuss the importance of effective communication and education during open enrollment to ensure that patients are informed about copay smoothing options.

Causal AI is an exciting technology that can enable next-best-action precision and organizational adaptability to support adherence and persistence at the individual patient level. This session will delve into the theory and practice behind Causal AI’s promise, including:

• The differentiating features of Causal AI from other technological advancements and the power of unlocking cause-and-effect relationships behind early patient discontinuation of specialty medications
• How counterfactual analyses can be used to tailor interventions to unique patient needs
• How Causal AI supports transparency and trust across stakeholders supporting the patient journey
• The diversity of datasets and information sources that Causal AI can leverage

Alongside key stakeholders, engage in conversation on how innovative digital platforms and strategies are transforming patient access. Uncover the future of digital solutions for payers and providers to optimize the patient journey.

With the election behind us and a new administration in place, the impact on healthcare legislation and regulatory priorities is coming into focus. This session examines key policy shifts, congressional dynamics and the evolving relationship between government and the life sciences sector.

• Assess how the new administration’s priorities and congressional leadership changes are shaping healthcare policies, including drug pricing, market access, and patient assistance programs.
• Examine the increasing trend of industry leaders being called to testify before Congress—will this continue, and what are the implications for pharma and patient access programs?
• Gain strategic insights into navigating the evolving political landscape, preparing for potential legislative changes and engaging effectively with policymakers